Prof Kumar Visvanathan
Professor Infectious Diseases
Department of Medicine
293 Scholarly works
20 Projects
HIGHLIGHTS
2026
Journal article
SAT-562 End-of-treatment biomarkers and HBV genotype predict severe biochemical flares after nucleos(t)ide analogue cessation: individual patient level meta-analysis of five prospective studies within the PROSTOP consortium
DOI: 10.1016/s0168-8278(26)02414-12026
Journal article
OS-101-YI Association between end-of-treatment biomarkers and HBV genotype in severe biochemical flares after nucleos(t)ide analogue cessation: results from five prospective studies within the PROSTOP consortium
DOI: 10.1016/s0168-8278(26)00412-52026
Journal article
Anti-HBs Immune Complex Levels: A Novel Marker of Hepatitis Flare Following Nucleos(t)ide Analog Withdrawal in HBeAg-negative Chronic Hepatitis B
DOI: 10.1093/infdis/jiaf5692026
Journal article
Long-Term Follow-Up of Patients in a Prospective Study of NA Discontinuation Identifies Different Patterns of HBsAg Loss
DOI: 10.1111/apt.703322023
Research grants (ARC, NHMRC, MRFF)
Novel Monoclonal Antibodies to Treat Chronic Hepatitis B
2023
Research Grant
Novel Monoclonal Antibodies to Treat Chronic Hepatitis B
2018
Research Grant
Novel Early Detection Strategy for Liver Cancer Using Hepatitis B Splice Variants to Expediate Diagnosis and Improve Treatment Outcome
RECENT SCHOLARLY WORKS
2026
Journal article
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UC
DOI: 10.1053/j.gastro.2025.07.0202026
Journal article
Monocyte Distribution Width Differentiates Bacterial Enterocolitis from Acute Severe Ulcerative Colitis in the Emergency Department
DOI: 10.1007/s10620-026-09786-w2025
Journal article
Effective real-world outcomes of remdesivir provided under compassionate access for moderate/severe COVID-19 in Australia
DOI: 10.1111/imj.701732025
Journal article
Su1880: EARLY SERUM AND FAECAL CYTOKINES PREDICT CLINICAL OUTCOMES IN ACUTE SEVERE ULCERATIVE COLITIS: RESULTS FROM PREDICT-UC
DOI: 10.1016/s0016-5085(25)02941-52025
Journal article
DOP057 Early serum and faecal cytokines predict clinical outcomes in Acute Severe Ulcerative Colitis: results from PREDICT-UC
DOI: 10.1093/ecco-jcc/jjae190.00962025
Journal article
DOP091 Early serum infliximab levels predict outcomes in Acute Severe Ulcerative Colitis: results from PREDICT-UC
DOI: 10.1093/ecco-jcc/jjae190.0130
RECENT PROJECTS
2023
Research Grant
Novel Monoclonal Antibodies to Treat Chronic Hepatitis B
2020
Research Contracts
Testing Immune-Mobilising Monoclonal T-Cell Receptors in Chronic Hepatitis B Patient-Derived Liver Organoids